Cancer Drug for Alzheimer's Treatment Camp Lejeune NC

New research suggests that a cancer drug might be able to restore day-to-day memory in patients with Alzheimer's disease. The disease, the most common form of dementia among the elderly, is expected to afflict 120 million people worldwide by 2050. Often the first sign is loss of short-term memory.

Neil Mac Connell King, MD
100 Brewster Blvd
Camp Lejeune, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Eastern Va Med Sch Of The Med Coll Of Hampton Roads, Norfolk Va 23501
Graduation Year: 1993

Data Provided by:
Sean Hsu
(910) 577-4300
215 Station St
Jacksonville, NC
Specialty
Neurosurgery

Data Provided by:
Coastal Neurological Assoc
(910) 353-3624
227 Memorial Dr
Jacksonville, NC

Data Provided by:
Diana Lynn Greene-Chandos
(336) 277-2200
2025 Frontis Plaza Blvd
Winston-Salem, NC
Specialty
Neurology

Data Provided by:
Giles Franklin Crowell, MD
175 Kimel Park Dr Ste 125
Winston Salem, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Bowman Gray Sch Of Med Of Wake Forest Univ, Winston-Salem Nc 27157
Graduation Year: 1979

Data Provided by:
Dr.Clarence Ballenger
(252) 633-3744
227 Memorial Drive
Jacksonville, NC
Gender
M
Speciality
Neurologist
General Information
Accepting New Patients: Yes
RateMD Rating
2.4, out of 5 based on 6, reviews.

Data Provided by:
Clarence Ballenger
(910) 353-3624
227 Memorial Dr
Jacksonville, NC
Specialty
Neurology, Alzheimer's Specialist

Robert A Nahouraii, MD
(704) 334-7311
1900 Randolph Rd Ste 1010
Charlotte, NC
Specialties
Neurology, Pediatrics
Gender
Male
Education
Medical School: Univ Of Pittsburgh Sch Of Med, Pittsburgh Pa 15261
Graduation Year: 1989
Hospital
Hospital: Carolinas Med Ctr, Charlotte, Nc; Presbyterian Hospital, Charlotte, Nc; Presbyterian Hosp Matthews, Matthews, Nc
Group Practice: Mecklenburg Neurological Associates

Data Provided by:
David Marshall Jones, MD
(828) 327-6500
1899 Tate Blvd SE Ste 2108
Hickory, NC
Specialties
Neurological Surgery
Gender
Male
Education
Medical School: Univ Of Va Sch Of Med, Charlottesville Va 22908
Graduation Year: 1983

Data Provided by:
Steven Mitchell Freedman, MD
(919) 782-3456
1540 Sunday Dr
Raleigh, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Univ Of Pa Sch Of Med, Philadelphia Pa 19104
Graduation Year: 1972
Hospital
Hospital: Wake Med Ctr, Raleigh, Nc
Group Practice: Raleigh Neurology Assocs

Data Provided by:
Data Provided by:

Cancer Drug for Alzheimer's Treatment

Provided By:

TUESDAY, Sept. 8 (HealthDay News) -- New research suggests that a cancer drug might be able to restore day-to-day memory in patients with Alzheimer's disease.

The disease, the most common form of dementia among the elderly, is expected to afflict 120 million people worldwide by 2050. Often the first sign is loss of short-term memory.

"People often joke that they must have Alzheimer's because they can't remember where they put their keys, but for a person with the disease, this type of short-term memory loss is extremely debilitating," study author Ottavio Arancio, an associate professor of pathology and cell biology at Columbia University Medical Center, said in a news release.

The researchers examined a cancer drug from a family of compounds called HDAC inhibitors. The drug tinkers with DNA, and in the mice the researchers studied it appeared to make it easier for neurons in the brain to manufacture new proteins.

That process is critical in the process of recording new memories.

"Because this type of drug has already been approved for some cancer patients, we hope that clinical trials for Alzheimer's disease can start in about three to four years," said co-author Mauro Fa, an associate research scientist at Columbia.

The findings appear in the September issue of the Journal of Alzheimer's Disease.

More information

Learn more about memory from McGill University.

SOURCE: Columbia University, news release, Sept. 3, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com